Materias dentro de su búsqueda.
Mostrando 4,041 - 4,060 Resultados de 4,918 Para Buscar '"Pfizer"', tiempo de consulta: 0.30s Limitar resultados
  1. 4041
    “…/NCI: Grant/Research Support|NIH/NIAID: Grant/Research Support|NIH/NIGMS: Grant/Research Support|Pfizer: Grant/Research Support|Regeneron Pharmaceuticals, Inc.: Grant/Research Support|SciClone Pharmaceuticals: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2509. Association of Non-Alcoholic Fatty Liver Disease with HBV, HAV, and HEV Exposure
  2. 4042
    “…Keller, MD, MPH, MSPH, Pfizer: Advisor/Consultant…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2417. Epidemiology of Central Line-Associated Bloodstream Infections Present on Hospital Admission: A Multicenter Study
  3. 4043
    “…DISCLOSURES: Regina Simeone, PhD, Pfizer: Stocks/Bonds Natasha B. Halasa, MD, MPH, Merck: Grant/Research Support|Quidell: Grant/Research Support|Quidell: donation of kits|Sanofi: Grant/Research Support|Sanofi: vaccine support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2351. Concordance Between Sources of COVID-19 Vaccination Information Among Children Aged 5–18 years, May 2021–March 2023
  4. 4044
    “…Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP, BD Biosciences: Advisor/Consultant|Cidara Therapeutics: Advisor/Consultant|GSK: Advisor/Consultant|Merck: Grant/Research Support|Open Forum Infectious Diseases: Board Member|Open Forum Infectious Diseases: Associate Editor|Pfizer: Advisor/Consultant Carolyn D. Alonso, MD, Academy for Continued Healthcare Learning: Honoraria|AiCuris: Advisor/Consultant|American Society of Healthcare Pharmacists: Honoraria|Cidara Therapeutics: Advisor/Consultant|Clinical Care Options: Honoraria|Merck: Advisor/Consultant|Merck: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    339. OPAT Outcomes in Patients with Immunocompromise
  5. 4045
    “…DISCLOSURES: Ashley Robinson, PhD, Pfizer: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1457. Carbapenem-resistant Acinetobacter baumannii in an Intensive Care Unit during the COVID-19 pandemic: An Outbreak Investigation Utilizing Whole Genome Sequencing
  6. 4046
    “…The major originator companies for these ARVs are: Abbott, Boehringer Ingelheim (BI), Bristol-Myers Squibb (BMS), Gilead, GlaxoSmithKline (GSK), Merck, Pfizer, Roche, and Tibotec. Beginning with zidovidine in 1987, all the drugs are available in the developed countries. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) – A Strategic Option for India
  7. 4047
    “…Data sources Bibliographic databases (Medline, Embase, PsycINFO, BIOSIS, and Cochrane Library), clinical trial registries, trial results databases, and regulatory authority websites up until February 2009, as well as unpublished data from the manufacturer of reboxetine (Pfizer, Berlin). Eligibility criteria Double blind, randomised, controlled trials of acute treatment (six weeks or more) with reboxetine versus placebo or SSRIs in adults with major depression. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials
  8. 4048
    por Vega, Silvio, Dowzicky, Michael J.
    Publicado 2017
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial
  9. 4049
    “…Hasbun, Biomeriaux: Consultant, Consulting fee; Biofire: Speaker’s Bureau, Speaker honorarium; Merck: Speaker’s Bureau, Speaker honorarium; Pfizer: Speaker’s Bureau, Speaker honorarium; Medicine’s Co: Speaker’s Bureau, Speaker honorarium; S. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiology of Meningitis and Encephalitis in Infants and Children in the United States from 2011 to 2014
  10. 4050
    “….: Grant Investigator, Research grant; Pfizer, Inc.: Grant Investigator, Research grant…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study
  11. 4051
    “…De Wals, GlaxoSmithKline: Grant Investigator and Scientific Advisor, Grant recipient and travel expenses. Pfizer: Grant Investigator and Scientific Advisor, Grant recipient and travel expenses. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Possible Impact of Wide-scale Vaccination Against Serogroup B Neisseria Meningitidis on Gonorrhea Incidence Rates in One Region of Quebec, Canada
  12. 4052
    “…DISCLOSURES: S. L. Kaplan, Pfizer: Grant Investigator and Speaker at PCV13 Launch Meeting in China, Research grant and Speaker honorarium…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Characterization and Biofilm Formation of Pediatric Staphylococcus aureus Device-related Infection Isolates Compared with Skin and Soft-tissue infection Isolates from 2008 to 2016
  13. 4053
    “…LaPlante, Merck: Grant Investigator, Grant recipient. Pfizer: Grant Investigator, Grant recipient. Cempra: Scientific Advisor, Consulting fee. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of minocycline, polymyxin B, meropenem, and amikacin on growth-prevention of Acinetobacter baumannii with various biofilm-forming capabilities
  14. 4054
    “…Astra Zeneca: Research Contractor, Grant recipient. W. Schaffner, Pfizer: Scientific Advisor, Consulting fee. Merck: Scientific Advisor, Consulting fee. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Estimated Hospitalization Rates for Seasonal Influenza in Adults and Children in Middle Tennessee using a Capture-Recapture Method
  15. 4055
    “…DISCLOSURES: W. Schaffner, Pfizer: Scientific Advisor, Consulting fee; Merck: Scientific Advisor, Consulting fee; Novavax: Consultant, Consulting fee; Dynavax: Consultant, Consulting fee; Sanofi-pasteur: Consultant, Consulting fee; GSK: Consultant, Consulting fee; Seqirus: Consultant, Consulting fee…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence of and Factors Associated with Clostridium difficile Co-infection Among Patients with Candidemia, United States, 2014–2016
  16. 4056
    “…Protein Sciences: Consultant, Consulting fee. E. T. Martin, Pfizer: Scientific Advisor, Research grant. Merck: Scientific Advisor, Research grant. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Influenza Vaccination and Treatment with Antiviral Agents Among Hospitalized Adults in the 2014–2015 and 2015–2016 Influenza Seasons
  17. 4057
    “…Methods A cohort of NSG (NOD/scid/gamma) mice was injected with ccRCC cells and treated with either the VEGF inhibitor SU (Sunitinib malate, Selleckchem, TX, USA) or the Notch pathway inhibitor GSI (Gamma secretase inhibitor, PF-03084014, Pfizer, New York, NY, USA), or started on SU and later switched to GSI (Switch group). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy
  18. 4058
    “…FUNDING: Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and Pfizer Inc. TRIAL REGISTRATION: Clinicaltrials.gov identifier NCT01986855. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study
  19. 4059
    “…[Image: see text] DISCLOSURES: C. Gross, Merck, Pfizer, Johnson and Johnson: Shareholder, stock. E. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1297. Characteristics for PrEP Uptake, Retention, and Discontinuation: Data From the ANCHOR Study
  20. 4060
    “…DISCLOSURES: J. M. Munita, Pfizer: Grant Investigator, Research grant. C. Arias, Merck & Co., Inc.: Grant Investigator, Research support. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1214. High Frequency of Genes Encoding Resistance to Heavy Metals in Methicillin-Resistant Staphylococcus aureus (MRSA) Endemic Lineages From South America
Herramientas de búsqueda: RSS